In this Clinical Conversations newsletter, Dr Scott Boswell shares how reframing prurigo nodularis (PN) and atopic dermatitis (AD) as neuroimmune-driven conditions has shaped his clinical philosophy. He shares his 3‑step approach to patient communication, highlights real‑world treatment journeys in PN and AD, and reflects on the impact of targeting IL‑31RA with NEMLUVIO® on managing chronic itch and supporting skin healing in appropriate patients.
advertisement
Discover Dr Boswell’s Perspective: Redefining PN and AD Through a Neuroimmune Lens
03/24/2026
Media formats available:
Formats
SaveCompleting the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
CAUTION: Spoilers ahead!
Finish the interactive case before reading the synopsis below.
Details
Recommended
Details
Overview
In this Clinical Conversations newsletter, Dr Scott Boswell shares how reframing prurigo nodularis (PN) and atopic dermatitis (AD) as neuroimmune-driven conditions has shaped his clinical philosophy. He shares his 3‑step approach to patient communication, highlights real‑world treatment journeys in PN and AD, and reflects on the impact of targeting IL‑31RA with NEMLUVIO® on managing chronic itch and supporting skin healing in appropriate patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?